tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Allogene Therapeutics says favorable result for Servier in Cellectis arbitration
PremiumThe FlyAllogene Therapeutics says favorable result for Servier in Cellectis arbitration
2M ago
Allogene Therapeutics’ ALPHA Study: A Promising Update in CAR T Cell Therapy
Premium
Company Announcements
Allogene Therapeutics’ ALPHA Study: A Promising Update in CAR T Cell Therapy
2M ago
Positive Outlook for Allogene Therapeutics: Buy Rating Backed by Promising Pipeline Advancements and Strong Financial Position
Premium
Ratings
Positive Outlook for Allogene Therapeutics: Buy Rating Backed by Promising Pipeline Advancements and Strong Financial Position
3M ago
Allogene Therapeutics’ Promising Study on LBCL Treatment with Cema-cel
PremiumCompany AnnouncementsAllogene Therapeutics’ Promising Study on LBCL Treatment with Cema-cel
5M ago
Allogene Therapeutics Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Allogene Therapeutics Earnings Call: Progress Amid Challenges
5M ago
Allogene Therapeutics management to meet with Piper Sandler
Premium
The Fly
Allogene Therapeutics management to meet with Piper Sandler
5M ago
Allogene Therapeutics options imply 16.7% move in share price post-earnings
PremiumThe FlyAllogene Therapeutics options imply 16.7% move in share price post-earnings
6M ago
Options Volatility and Implied Earnings Moves Today, August 13, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, August 13, 2025
6M ago
Is ALLO a Buy, Before Earnings?
Premium
Pre-Earnings
Is ALLO a Buy, Before Earnings?
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100